Sales rise 40.70% to Rs 3.63 crore
Net profit of Beryl Drugs reported to Rs 0.10 crore in the quarter ended December 2017 as against net loss of Rs 0.09 crore during the previous quarter ended December 2016. Sales rose 40.70% to Rs 3.63 crore in the quarter ended December 2017 as against Rs 2.58 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales3.632.58 41 OPM %6.892.33 -PBDT0.230.01 2200 PBT0.13-0.09 LP NP0.10-0.09 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content